genitourinary oncology

Open Access
Developing a Patient-Reported Outcome Measure for Radionuclide Therapy for Prostate Cancer
Lisa M. Gudenkauf, Melody N. Chavez, Melinda Leigh Maconi, Carley Geiss, Ameen Seyedroudbari, Pan Thin, Aasha I. Hoogland, Kathleen Nguyen, Vishnu Murthy, Wesley R. Armstrong, Khaled Komrokji, Laura B. Oswald, Heather S.L. Jim, Ghassan El-Haddad, Wolfgang P. Fendler, Ken Herrmann, David Cella, Johannes Czernin, Michael S. Hofman, Adam P. Dicker, Jeremie Calais, Scott T. Tagawa and Brian D. Gonzalez

Journal of Nuclear Medicine June 1, 2023, 64 (6) 869-872; DOI: https://doi.org/10.2967/jnumed.122.264946
You have access
Liver Enzyme Elevation After ¹⁷⁷Lu-PSMA Radioligand Therapy for Metastasized Castration-Resistant Prostate Cancer
Hannes Treiber, Alexander König, Albrecht Neesse, Annika Richter, Carsten Oliver Sahlmann and Arne Strauss

Journal of Nuclear Medicine July 1, 2021, 62 (7) 1016-1019; DOI: https://doi.org/10.2967/jnumed.120.258533
You have access
Intraindividual Comparison of ^99mTc-Methylene Diphosphonate and Prostate-Specific Membrane Antigen Ligand ^99mTc-MIP-1427 in Patients with Osseous Metastasized Prostate Cancer
Hendrik Rathke, Ali Afshar-Oromieh, Frederik Lars Giesel, Christophe Kremer, Paul Flechsig, Sabine Haufe, Walter Mier, Tim Holland-Letz, Maximilian De Bucourt, Thomas Armor, John W. Babich, Uwe Haberkorn and Clemens Kratochwil

Journal of Nuclear Medicine September 1, 2018, 59 (9) 1373-1379; DOI: https://doi.org/10.2967/jnumed.117.200220

Main menu